Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Tarceva Italian Lung Optimization tRial
- Status
- UNKNOWN
- Phase
- PHASE3
Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE3